M
Metropolis Healthcare Ltd
Healthcare
₹ 2,020.10 +69.80 (3.58%)
₹ 2,020.10 +69.80 (3.58%)
- NSE
- BSE
Overview
- BSE Code 542650
- NSE Symbol METROPOLIS
- ISIN Demat INE112L01020
- Book Value (₹) 240.23
- Face Value (₹) 2.00
- Market Cap (₹ Cr.) 10,035.06
- P/E (TTM) 80.42
- EPS (TTM) 24.09
- Div Yield (%) 0.00
Performance
Today’s Low 1,945.50
Today’s High 2,034.90
52W Low 1,315.00
52W High 2,318.30
Open 1,950.00
Prev. Close 1,950.30
Volume 1,83,688.00
Corporate Actions
Metropolis Healthcare Limited - Updates
Apr 18, 2025Metropolis Healthcare Limited has informed the Exchange regarding 'Allotment of 1,836 equity shares under the Metropolis-Restrictive Stock Unit Plan, 2020'.
Metropolis Healthcare Limited - Alteration Of Capital and Fund Raising-XBRL
Apr 18, 2025METROPOLIS HEALTHCARE LIMITED has informed the Exchange regarding Allotment of Securities
About Metropolis Healthcare Ltd
Metropolis Healthcare Limited is one of the leading diagnostics companies in India. It owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East. The Chairman, Dr Sushil Shah, founded the company in 1981 and established the first referral laboratory. In 1992, It started clinical research services. The company continued its organic growth and finished its first major acquisition of Sudharma in Kerala in 2001. During the same year, the company started the home service vertical.
In 2013, it expanded the services of Metropolis to developing African countries. After three years, the company inducted the new professional management team and rolled out Metropolis's retail strategy in 2016. The company was listed on the Indian stock exchanges successfully in 2019 after an IPO to the public. In 2023, it launched Metropolis 3.0 strategy to broaden its consumer reach via the Direct to Consumer (D2C) model with a core priority on building chronic and wellness businesses.
Business Segments
- Pathology Testing Services:Under this segment, the company offers services such as Blood Tests, Diagnostics and Wellness services. It has operations across India, Africa, South Asia, and the Middle East.
- Corporate Wellness:Under this segment, it ties up with organizations and offers pre-employment check-ups, employee health plans, and annual check-ups for corporates to build a healthy workforce.
- Lab in Hospitals:The company partnerswith hospitals to provide diagnostics services. Currently, it is a partnership with many hospitals across geographies and delivers full-scale in-house pathology services and solutions.
- Clinical Research Services:It delivers analytical and support services such as logistics and EDI to contract research organizations for their clinical research projects.
- Amin's Pathology Laboratory Private Limited:It is a wholly-owned subsidiary which offers over 50 different types of medical with the latest and the best automated equipment.
- Centralab Healthcare Services Private Limited:This is a wholly owned subsidiary which is engaged in providing healthcare services to customers.
Key Personnel:
Dr Sushil Shah, Chairman and Executive Director Dr. Sushil Shah is the Founder and Chairman of the company. He completed his M.B.B.S. in 1972 and M.D. in Pathology and Bacteriology from Grant Medical College in 1975. In 1978, he received a Research Fellowship in Endocrine Pathology at the esteemed Cornell Medical Centre. Ms Ameera Shah, Promoter and Managing Director Ms Ameera Shah is the Promoter and Managing Director of the company. She is a global thought leader in the healthcare industry and played an instrumental role in changing the pathology industry landscape in the country.Corporate Action
The company has no history of bonus issues, stock splits and other corporate actions.| Founded | : 2000 |
| Chairman | : Ameera Sushil Shah |
| Address | : 250 D Udyog Bhavan, Worli, Mumbai, Maharashtra, 400030, |
Open A Free Demat Account Today
Get StartedDocuments To Be Kept Handy
- PAN Card
- Cancelled Cheque
- Latest 6 month Bank Statement (Only for Derivatives Trading)